(2-methoxy-4-(piperazin-1-yl)phenyl)boronic acid is primarily utilized in organic synthesis and medicinal chemistry as a key intermediate for the development of pharmaceutical compounds. Its boronic acid group makes it valuable in Suzuki-Miyaura cross-coupling reactions, which are widely employed to construct complex organic molecules, particularly in the synthesis of biologically active compounds. The piperazine moiety in its structure enhances its potential in designing drug candidates, especially for targeting central nervous system disorders, due to its ability to interact with neurotransmitter receptors. Additionally, this compound is explored in the development of protease inhibitors and other therapeutic agents, leveraging its unique chemical properties for drug discovery and optimization.